AHCC06

AHCC 06

Phase III Multi-Centre Open-Label Randomized Controlled Trial of Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (NCT01135056) 

Status

Complete Recruitment; planned sample size of 360 patients. Results to be presented at 2017 ASCO Annual Meeting on 4 June 2017.

Contributing Principal
Investigators and Centres

Brunei 
Kenneth Kok (The Brunei Cancer Centre)

Hong Kong 
Ronnie Poon (Queen Mary Hospital)

Indonesia 
L.A Lesmana (Cipto Mangunkusumo Hospital, University of Indonesia) Tjakra Wibawa Manuaba (Sanglah General Hospital, Denpasar)

South Korea 
Hyun-Ki Yoon (Asan Medical Center) Yun-Hwan Kim (Korea University Anam Hospital) Ho-Seong Han (Seoul National University Bundang Hospital) Si-Hyun Bae (Seoul St Mary’s Hospital) Jong Yun Won (Severance Hospital, Yonsei University) Jin-Mo Yang (St Vincent’s Hospital)

Malaysia 
Aloysius Raj (Penang Adventist Hospital) James Law Chiong Soon (Sarawak Hospital) Yoong Boon Koon (University Malaya Medical Center)

Mongolia 
Ariunaa Khasbazar (National Cancer Center of Mongolia)

Myanmar 
Khin Maung Win (Yangon GI & Liver Centre)

New Zealand 
Adam Bartlett (Auckland City Hospital)

Philippines 
Rolley Lobo (Davao Doctors Hospital) Catherine Teh (Makati Medical Center) Janus Ong (The Medical City) Ian Cua (St Luke’s Medical Center)

Singapore 
Jessica Tan (Changi General Hospital) Tan Tzu Jen (Khoo Teck Puat Hospital) Choo Su Pin (National Cancer Centre Singapore) Stephen Chang (National University Hospital) Cheow Peng Chung (Singapore General Hospital)

Taiwan 
Chien-Fu Hung (Chang Gung Memorial Hospital) Chao-Long Chen (Chang Gung Memorial Hospital, Kaohsiung) Cheng-Yuan Peng (China Medical University Hospital) Po-Chin Liang (National Taiwan University Hospital)  Rheun-Chuan Lee (Taipei Veterans General Hospital)

Thailand 
Chanisa Chotipanich (Chulabhorn Hospital)

Protocol Chair

Pierce Chow 
pierce.chow.k.h@singhealth.com.sg